FDA Inspection 1224785 — Teva Canada Limited
The FDA completed an inspection of Teva Canada Limited on November 10, 2023 in Scarborough. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- November 10, 2023
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Scarborough (Canada)